Glaxosmithkline Pharmaceuticals informs about disclosure

06 Dec 2023 Evaluate
Glaxosmithkline Pharmaceuticals has informed that it enclosed disclosure under Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015.

The above information is a part of company’s filings submitted to BSE.

Glaxosmithkline Phar Share Price

2627.50 -23.35 (-0.88%)
26-Feb-2026 16:01 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1787.50
Dr. Reddys Lab 1315.00
Cipla 1357.80
Zydus Lifesciences 938.50
Lupin 2323.85
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×